Azenta Inc. is a leading provider of sample management solutions and life science tools, specializing in enhancing laboratory efficiencies for the biotechnology and pharmaceutical sectors. Leveraging innovative automated solutions, biorepository services, and advanced storage technologies, the company empowers clients to accelerate drug discovery while maintaining strict regulatory compliance. With a strong focus on cutting-edge technology and collaborative partnerships, Azenta is strategically positioned to capitalize on growth opportunities within the expanding global life sciences market. Its unwavering commitment to advancing scientific research through sophisticated products further reinforces its competitive edge in biobanking and sample management.
| Revenue (TTM) | $595.03M |
| Gross Profit (TTM) | $265.16M |
| EBITDA | $37.33M |
| Operating Margin | -4.10% |
| Return on Equity | 1.53% |
| Return on Assets | -0.59% |
| Revenue/Share (TTM) | $12.99 |
| Book Value | $37.26 |
| Price-to-Book | 0.61 |
| Price-to-Sales (TTM) | 1.75 |
| EV/Revenue | 1.155 |
| EV/EBITDA | 18.44 |
| Quarterly Earnings Growth (YoY) | 8778.00% |
| Quarterly Revenue Growth (YoY) | 0.80% |
| Shares Outstanding | $46.06M |
| Float | $40.65M |
| % Insiders | 0.92% |
| % Institutions | 116.15% |